Jesús Rodríguez Baño
@jesusrbano.bsky.social
ID physician (HUVMacarena) and professor of Medicine (University of Sevilla). Past President of ESCMID.
#MarianaGuedes presented our results from WP3 at #PrIMAVeRA project 4th annual meeting. Brilliant as usual.
☝️Anonimised sharable data from >14,000 patients with infections by AMR & susceptible pathogens for math modelling and other analysis
☝️Anonimised sharable data from >14,000 patients with infections by AMR & susceptible pathogens for math modelling and other analysis
November 6, 2025 at 1:53 PM
#MarianaGuedes presented our results from WP3 at #PrIMAVeRA project 4th annual meeting. Brilliant as usual.
☝️Anonimised sharable data from >14,000 patients with infections by AMR & susceptible pathogens for math modelling and other analysis
☝️Anonimised sharable data from >14,000 patients with infections by AMR & susceptible pathogens for math modelling and other analysis
Reposted by Jesús Rodríguez Baño
November 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...
#IDSky #MicroSky
#IDSky #MicroSky
October 24, 2025 at 8:04 AM
November 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...
#IDSky #MicroSky
#IDSky #MicroSky
Reposted by Jesús Rodríguez Baño
The Editor-in-Chief of Clinical Microbiology and Infection, Leonard Leibovici, will be stepping down and replaced by Jesús Rodríguez Baño on 1 Jan 2026. Read their editorials plus one by our Publications Counsellor:
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
November 1, 2025 at 11:05 AM
The Editor-in-Chief of Clinical Microbiology and Infection, Leonard Leibovici, will be stepping down and replaced by Jesús Rodríguez Baño on 1 Jan 2026. Read their editorials plus one by our Publications Counsellor:
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
Big honor and huge challenge. Thanks to Leonard Leibovici for mastering and to @escmid.bsky.social Executive Committee for the confidence
The Editor-in-Chief of Clinical Microbiology and Infection, Leonard Leibovici, will be stepping down and replaced by Jesús Rodríguez Baño on 1 Jan 2026. Read their editorials plus one by our Publications Counsellor:
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
November 1, 2025 at 7:20 PM
Big honor and huge challenge. Thanks to Leonard Leibovici for mastering and to @escmid.bsky.social Executive Committee for the confidence
Thanks @drandrekalil.bsky.social
🆕 “Individualised duration of treatment in febrile urinary tract infection: ready for prime time?”
Excellent article just out by @jesusrbano.bsky.social and Zaira Palacios-Baena @lancetID.bsky.social👇
www.thelancet.com/journals/lan...
Excellent article just out by @jesusrbano.bsky.social and Zaira Palacios-Baena @lancetID.bsky.social👇
www.thelancet.com/journals/lan...
Individualised duration of treatment in febrile urinary tract infection: ready for prime time?
The duration of antimicrobial treatment is currently a hot topic in the field of infectious
diseases. For decades, the prevailing belief was that long treatments were essential
to prevent relapses. Th...
www.thelancet.com
September 15, 2025 at 5:13 AM
Thanks @drandrekalil.bsky.social
Reposted by Jesús Rodríguez Baño
Todos los pacientes con bacteriemia por Staphylococcus aureus deben ser evaluados clínicamente por un especialista en enfermedades infecciosas.
April 20, 2025 at 7:50 AM
Todos los pacientes con bacteriemia por Staphylococcus aureus deben ser evaluados clínicamente por un especialista en enfermedades infecciosas.
Want to know if temocillin is non-inferior to meropenem in BSI by 3GCeph resistant enterobacteria?
We are presenting the results of ASTARTÉ trial at ESCMID Global Sunday 16:15 Hall 9.
#ESCMIDGlobal
We are presenting the results of ASTARTÉ trial at ESCMID Global Sunday 16:15 Hall 9.
#ESCMIDGlobal
April 12, 2025 at 3:24 PM
Want to know if temocillin is non-inferior to meropenem in BSI by 3GCeph resistant enterobacteria?
We are presenting the results of ASTARTÉ trial at ESCMID Global Sunday 16:15 Hall 9.
#ESCMIDGlobal
We are presenting the results of ASTARTÉ trial at ESCMID Global Sunday 16:15 Hall 9.
#ESCMIDGlobal